Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: Spain Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20073
20104
20123
20131
20141
20161
20173
20181
20193
20201
20212
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated3
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
GlaxoSmithKline5
Novartis Pharmaceuticals3
Pfizer3
Novartis2
Palobiofarma SL2
Actelion1
Boehringer Ingelheim1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive29
Asthma2
Bronchitis, Chronic2
Emphysema2
Hypertension, Pulmonary2
Lung Diseases2
Respiration Disorders2
Body Weight1
Herpes Zoster1
Inflammation1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.